Our Team | PainChek

Our Team

Strong track record in clinical practice, R&D, innovation and commercialisation

Philip Daffas

CEO & Managing Director, MBA, BSc

Philip is a highly accomplished global business leader and people manager with an international career spanning more than 25 years with leading blue-chip healthcare corporates and novel technology start-up companies.

Philip has held senior global business leadership positions in Europe, US and Australia. He has been instrumental in building businesses, growing market share and developing extensive high-level customer relationships in each sector.

Philip’ roles in Australia have included VP Global Marketing at Cochlear and General Management with Roche Diagnostics and Bio-Rad Laboratories, and CEO of Applied Physiology, an Australian start up software company in the intensive care monitoring sector.

Philips’ earlier experience was gained in Europe with market leaders such as IVAC infusion systems and Shiley cardiopulmonary products. He subsequently joined Boehringer Mannheim, initially in the UK managing their diagnostics business and subsequently was promoted to Global Marketing Director in the Diabetes Care business based in Mannheim, Germany.

In 1997 Philip joined Cochlear in the UK as the European Sales and Marketing Manager and subsequently was promoted to the VP Global Marketing role based in Sydney, Australia.

Prof. Jeff Hughes

Chief Scientific Officer PhD, MPS

Jeff is a professor in the School of Pharmacy, Curtin University in Western Australia. Jeff served as the Head of the School of Pharmacy of Curtin University, from March 2009 to May 2014. Jeff is one of the team who invented the ePAT App and since March 2015 has been the CEO of ePAT.

He is recognised as a leader in clinical pharmacy research, education and practice in Australia. He was the recipient of the 1998 Society of Hospital Pharmacists of Australia’s (SHPA) Glaxo Medal of Merit and in 2001 received SHPA’s Clinical Pharmacy award. Further, in 2004 his efforts in the areas of clinical pharmacy education and pharmacy research were acknowledged when he was named the Pharmaceutical Society of Australia’s (PSA) Pharmacist of the Year. More recently he received the 2008 Eric Kirk Memorial Award from the Pharmaceutical Society of Western Australia, the 2009 AACP-Pfizer Consultant Pharmacist Award and the 2014 Australasian Pharmaceutical Sciences Association Medal.

Jeff is currently a Director of the Pharmaceutical Society of Western Australia and the Pharmaceutical Society of Australia of which he is the National Vice President and the Chair of the Financial, Audit and Risk Management Committee. Jeff is also a community pharmacy proprietor and a practising accredited pharmacist.

Jeff has contributed significantly to clinical pharmacy education and practice through his role as the Consultant Editor of the “Australian Pharmacy” and editorial membership of the “Journal of Pharmacy Practice and Research”. He has also supervised numerous PhD, Masters and Honours candidates to completion and acted as a mentor for early career researchers. Jeff has an extensive publication record contributing to a large number of books (as an author/editor) and articles in peer review and professional journals.

PainChek Ltd

Dr Kreshnik Hoti

Senior Research Scientist PhD, MPS

Kreshnik is a registered community and consultant pharmacist with a PhD in Pharmacy and an accreditation from the Australian Association of Consultant Pharmacy. Dr Hoti has extensive practice experience in reviewing the use and safety of medicines in community and aged care settings, especially in geriatric people with chronic conditions. Ensuring adequate pain management was a key focus in Kreshnik extensive experience with medication reviews in the elderly, including those with dementia.

Kreshnik has established inter-professional education and practice programs in specialised dementia aged care facilities and has developed dementia focused workshops. Kreshnik has served as an expert witness for Western Australia’s clinical senate and has facilitated training of Western Australian general practitioners and registrars on collaborative practice through WAGPET.

Kreshnik has participated in a number of collaborative research projects contributing to research design, data analysis, interpretation of findings and report/publication writing. He is a recipient of competitive funding from Alzheimer’s Australia and is one of the co-inventors of the ePAT App. Dr Hoti currently holds an Adjunct Senior Lecturer position at the School of Pharmacy, Curtin University and has been recently elected Vice-Dean for Academic Affairs at the Faculty of Medicine, University of Prishtina, Kosovo.

Mustafa Atee

Research Scientist MPS, PhD (candidate)

Mustafa is a clinical, community and academic pharmacist. Throughout his 11-year career in pharmacy, he has managed a number of community pharmacies in Western Australia. Mr Atee holds a postgraduate diploma and master degrees in clinical pharmacy.

Mustafa is currently studying a PhD with the School of Pharmacy at Curtin University which focuses on improving pain management amongst people with dementia. The ePAT concept was born out of his PhD research. His PhD research has been supported by both a grant and an academic scholarship from Alzheimer’s Australia. Mustafa’s project was a finalist in the Incite Awards, OzApp and LESANZ Awards. Mustafa is also an academic mentor and lecturer with Curtin University and Curtin College.

Ian Hobson

Company Secretary

Ian is a chartered accountant and chartered secretary who acts as non-executive director and company secretary to ASX listed companies, trustee corporations, charitable trusts and private organisations. Prior to commencing his own practice, Ian had in excess of 20 years professional accounting experience working for large chartered accounting firms together with commercial experience in Australia, UK and Canada.

As an experienced finance and corporate governance professional, Ian brings a wealth of experience to boards contributing to financial management, corporate governance, capital raising strategies and transaction and due diligence capabilities drawn from exposure to a variety of industries.

Ian is a facilitator with the AICD and presents the finance units for the Company Director Course.

Scott Robertson

Chief Technology Officer, MBA, B.Eng.(Comp. Systems)

Scott has over 25 years’ experience designing, deploying and managing enterprise software systems.

Scott has mostly worked in private enterprises, where adapting to changing client needs, markets directions and government regulations were paramount to commercial success.

Scott started his career as an engineer with the NSW State Rail corporation, before transitioning to the private sector in 1997.  Since then he’s spend time mainly in the telecommunications and billing industries on a variety of domestic and international projects.

PainChek Ltd

David Allsopp

Head of Business Development ANZ

David joins us with 15 years’ experience in the account management, relationship management and business development space. Ten of those spent in the aged care sector and earlier in media.

With close ties in the allied healthcare and aged care space, David has built a reputation for being an expert in the aged care field. A combined decade long tenure at HealthStrong and most recently Mirus Australia have instilled deep domain knowledge in aged care legislation from a revenue and qualitive perspective.

A passion for improving aged care and assisting in business outcomes has seen David work closely with large listed, church and charitable and single site organisations.

David is renowned for and prides himself on establishing trusting, transparent and long-standing relationships in the healthcare space.

Pete Shergill

Business Development Director, PainChek UK

Pete is a UK Healthcare Market leader with over 15 years of senior management experience across Health and Social Care. His experience spans Multi-site Operations, B2B Business Development, Software Deployment, Innovative Market Proposition Launches, NHS and Private Hospitals.

Pete has previously been involved in the integration of UK pharmacy solutions across the hospital, retail, wholesale, care home and homecare pharmacy settings for Lloyds Pharmacy and McKesson UK. Through his leadership, he has secured over £1bn of tendered business including the provision of services to the London 2012 Olympics and the Ministry of Defence.

Pete, as a Healthcare Professional (Pharmacist), has a particular drive to meet client/patient needs and making a real difference to the way in which health and social care is delivered in the UK; leading him to join iCareHealth Ltd in 2015 and Access Group in 2018, where he has helped the Social Care sector modernise through the use of digital care and medication technologies.

His personal interests include modern classic cars, cycling and the occasional self-build property project.

Dawn Kerr

Senior Clinical Specialist

Dawn joins us with 16 years’ nursing experience. She completed her nurse training at West of Scotland University in Glasgow, where she graduated with a BSc in Adult Nursing.  She moved to Australia in early 2006, starting her Australian nursing career in Adelaide working in CCU and ICU.  Dawn has a wealth of experience working as a Clinical Nurse Specialist based in acute care.  She moved to Sydney to work at Prince of Wales Private Hospital within a general surgical unit.

As a senior registered nurse and with a passion for pain management, Dawn moved in to the role of Pain Management Clinical Nurse Specialist and later promoted to Clinical Nurse Consultant. Over an 8 year period working in the pain management environment,  she assisted in the development and ongoing management of an Acute Pain Service within the hospital, the service later developed to offer a Chronic Pain Service to patients with chronic pain, during their hospital stay and assisting with their discharge planning. Dawn joins PainChek with an extensive knowledge in the area of pain management nursing, she is patient orientated in providing care and believes pain management is of paramount importance in any care facility. Dawn strives to improve processes to manage pain across all health care settings, promoting quality of life and ensuring evidence based nursing practice.

Our Board

John Murray

Non-Executive Director and Non-Executive Chairman of the Board

John has over 20 years’ experience in private equity and venture capital, and was a co- founder and Managing Partner of Technology Venture Partners; one of the original and leading venture capital firms in Australia. John is a past chairman of the Australian Venture Capital Association. John has considerable experience as a director of high growth, technology-based companies. He possesses a broad understanding of global trends in technology and its impact on a variety of industries. He is currently Chairman of a private aged care business (IBIS Care Group) and a non-executive director of Maestrano (cloud software technology). John also brings 12 years’ experience in executive roles in corporate banking (Bank America Vice President), accounting and IT services industries.

John has been on the Board of a number of successful technology rollouts and exits including online travel play Viator, which was acquired by TripAdvisor for approximately US$200 million in 2014. He is a chartered accountant with an Honour degree in Law, and is a member of the Australian Institute of Company Directors.

Philip Daffas

CEO & Managing Director, MBA, BSc

Philip is a highly accomplished global business leader and people manager with an international career spanning more than 25 years with leading blue-chip healthcare corporates and novel technology start-up companies.

Philip has held senior global business leadership positions in Europe, US and Australia. He has been instrumental in building businesses, growing market share and developing extensive high-level customer relationships in each sector.

Philip’ roles in Australia have included VP Global Marketing at Cochlear and General Management with Roche Diagnostics and Bio-Rad Laboratories, and CEO of Applied Physiology, an Australian start up software company in the intensive care monitoring sector.

Philips’ earlier experience was gained in Europe with market leaders such as IVAC infusion systems and Shiley cardiopulmonary products. He subsequently joined Boehringer Mannheim, initially in the UK managing their diagnostics business and subsequently was promoted to Global Marketing Director in the Diabetes Care business based in Mannheim, Germany.

In 1997 Philip joined Cochlear in the UK as the European Sales and Marketing Manager and subsequently was promoted to the VP Global Marketing role based in Sydney, Australia.

Ross Harricks

Non-Executive Director, BSc, BEng(Hons), MBA (Distinction)

Ross’ experience in the commercialisation of medical products spans over thirty years and over three continents.

He began in the medical industry in the UK, marketing CT scanners and then moving to Australia to set up his company’s regional sales operation. In 1983, Ross joined the Nucleus Group as Group Marketing Executive and became President of Group subsidiaries in United States in marketing medical equipment and scientific computing products.

In 1989, Ross was the CEO of a US-based start-up company developing specialist medical lasers. He then returned to Australia and has been a director of ResMed Limited and cofounder of AtCor Medical where he completed an Australian initial public offering in 2005 leading the company until 2007.

Ross now works with early stage Australian medical technology companies on their business development and expansion into the US and EU markets.

Adam Davey

Non-Executive Director

Adam is the Director, Private Clients and Institutional at Patersons Securities. His expertise spans over 25 years and includes ASX Listings, Capital Raising (both private and public), Mergers and Acquisitions as well as Transaction Due Diligence.

Adam has held various roles within different organizations including Chairman, Managing Director as well as Corporate Adviser to the board.